ArticleScientific reports2025
Visible light photocatalytic degradation of tamoxifen using covalent organic triazine polymer.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metal-free, environmentally friendly photocatalysts offer a valuable alternative to conventional metal-based semiconductors. In this study, we developed a photocatalyst based on a covalent organic triazine polymer (COTP) using an efficient synthetic route. Comprehensive characterization was conducted to assess the physical (TEM, FESEM-EDS, and elemental mapping), chemical (FTIR and XRD), and optical (UV-Vis-DRS) properties of the synthesized photocatalyst and to evaluate its photocatalytic performance for the selective oxidation of tamoxifen (TMX) when exposed to visible light. The COTP exhibited remarkable photocatalytic efficiency, achieving a rate constant of 0.0599 min
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.